CAM
ICPT

ClariVest Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

ClariVest Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-38,728
Closed -$429K – 866
2023
Q2 		$429K Buy
+38,728
New +$540K 0.02% 359
2014
Q2 		– Sell
-1,739
Closed -$574K – 637
2014
Q1 		$574K Buy
+1,739
New +$587K 0.02% 257

Other funds holding ICPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

ClariVest Asset Management's ICPT Position: Q3 2023 in Review

ClariVest Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 38,728 shares — an estimated $429K sold.

ClariVest Asset Management first reported a position in ICPT in Q1 2014 and held it in 2 quarters. The position peaked at $574K in Q1 2014. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • ClariVest Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • ClariVest Asset Management sold 38,728 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $429K.
  • ClariVest Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • ClariVest Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $574K in Q1 2014.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on ClariVest Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.